Tenet Healthcare Corporation (THC - Free Report) delivered second-quarter 2018 adjusted net income of 49 cents per share, outperforming the Zacks Consensus Estimate by 104.2%. The upside is primarily driven by the performance of Ambulatory Segment. Moreover, the bottom line rebounded from the year-ago loss of 17 cents.
Quarterly Operational Update
Net operating revenues came in at $4.5 billion, down 6.2% year over year. Additionally, the top line missed the Zacks Consensus Estimate by 1.6%. This was due to weak performances by the Hospital and other plus Conifer segments.
Tenet Healthcare’s same-hospital exchange admissions were 4,725, down 5.6 % year over year.
Same-hospital exchange outpatient visits were 51,845, up 0.6% year over year.
Quarterly Segment Details
Hospital & Other
Net operating revenues in the Hospital Operations and Other segment came in at $3.7 billion, down 8.6% year over year This downside is largely attributable to hospital divestitures and a decline in health plan business.
On same-hospital basis, patient revenues were $3.4 billion, up 3.2% year over year.
Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) was $345 million, down 0.3% year over year.
The Ambulatory segment generated net operating revenues of $531 million, up 12.5% year over year.
Additionally, the segment reported adjusted EBITDA of $198 million, up 20.7% year over year.
Conifer’s revenues decreased 3.5% from the prior-year quarter’s level to $386 million. This was mainly due to the company’s divestiture activities.
The segment reported $91 million of adjusted EBITDA in the quarter under review, up 51.7% year over year.
As of Jun 30, 2018, Tenet Healthcare had cash and cash equivalents of $403 million, down 34% from the number at year-end 2017.
The company exited the second quarter with $14.2 billion of long-term debt, down 3.4% from the count at 2017 end.
Net cash provided by operating activities for the first half of 2018 stands at $461 million, up 15% year over year.
Adjusted earnings per share are projected between $1.54 and $1.88, up from the earlier projection of $1.36-$1.70.
Tenet Healthcare retains its expectation for revenues in the range of $17.9-$18.3 billion.
Adjusted EBITDA is reaffirmed between $2.55 billion and $2.65 billion.
Tenet Healthcare reiterates adjusted its free cash flow of $725-$925 million. However, the company has lowered its net cash provided by operating activities from $1.245-$1.550 billion to $1.220-$1.525 billion.
The company now anticipates revenues in the range of $4.3-$4.5 billion, down from the earlier projection of $4.475-$4.675 billion.
The company now envisions adjusted EBITDA between $575 million and $625 million, down from the previous prediction of $605-$655 million.
Adjusted earnings per share from continuing operations are likely to vary between 10 cents and 24 cents, down from the past estimate of 15-29 cents.
Zacks Rank and Performance of Other Players
Tenet Healthcare carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Among other players from the HMO industry having reported second-quarter earnings so far, the bottom line of Anthem Inc. (ANTM - Free Report
) , Centene Corporation (CNC - Free Report
) and UnitedHealth Group Inc. (UNH - Free Report
) beat the respective Zacks Consensus Estimate.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>